Using pyridoxine to treat carpal tunnel syndrome. Randomized control trial.

Abstract

In this study, we examined prospectively the effect of pyridoxine on idiopathic carpal tunnel syndrome. Thirty-two patients with the disease were randomized to receive treatment or placebo. No differences in outcome were found in electrophysiologic signs, clinical signs, or significant symptoms. Our findings do not support the use of pyridoxine for treating carpal tunnel syndrome.

• Authors: G R Spooner, H B Desai, J F Angel, B A Reeder, J R Donat
• Journal: Canadian family physician Medecin de famille canadien (Can Fam Physician) Vol. 39 Pg. 2122-7 (Oct 1993) ISSN: 0008-350X [Print] Canada
• PMID: 8219859 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)

Chemical References

• Placebos
• Pyridoxal Phosphate
• Aspartate Aminotransferases
• Pyridoxine

Topics

• Adolescent
• Adult
• Aged
• Aspartate Aminotransferases (blood)
• Carpal Tunnel Syndrome (drug therapy, physiopathology)
• Double-Blind Method
• Female
• Humans
• Male
• Median Nerve (physiopathology)
• Middle Aged
• Motor Neurons (physiology)
• Neural Conduction (physiology)
• Patient Compliance
• Placebos
• Pyridoxal Phosphate (blood)
• Pyridoxine (administration & dosage, blood, therapeutic use)
• Reaction Time (physiology)